Pressure-volume analysis as a method for quantifying simultaneous drug (amrinone) effects on arterial load and contractile state in vivo

Division of Cardiology, Johns Hopkins University Medical Institutions, Baltimore, Maryland.

Pressure-volume relation analysis was used to independently quantify changes in ventricular contractile performance and vascular loading in intact anesthetized dogs before and after a single bolus of intravenous amrinone. Ventricular systolic property changes were characterized by the end-systolic elastance (Ees = slope of the end-systolic pressure-volume relation) and arterial properties by the effective arterial elastance (Ea = end-systolic pressure/stroke volume ratio). Pressure-volume data were obtained by the conductance catheter technique with loading varied by transient inferior vena cava occlusion. Amrinone induced a 27% increase in ejection fraction at 10 min (from 44% to 56%) as a result of both a significant rise in contractility (mean Ees 4 +/- 2 to 6 +/- 3 mm Hg/ml, p less than 0.001) and simultaneous reduction in arterial loading (Ea reduction from 6 +/- 2 mm Hg/ml to 5 mm Hg/ml, p less than 0.001). Over the subsequent 30 min, Ea revealed a significant recovery toward baseline, whereas Ees was less altered. Mean percent changes (% delta) in both variables were linearly correlated: % delta Ea = -1.6 x % delta Ees + 3.1, r = 0.96, p less than 0.001. In addition to separating ventricular from vascular property changes, the pressure-volume coupling framework was used to predict net pump performance (ejection fraction). Model predictions showed good agreement with experimental data. Thus, pressure-volume relations can be used to separately quantitate simultaneous changes in ventricular and vascular loading properties in vivo produced by pharmacologic agents with complex actions. Use of this approach in drug testing in humans should simplify data interpretation regarding mechanisms of action in specific clinical settings.

This article has been cited by other articles:

				T. L. Bale, M. Hoshijima, Y. Gu, N. Dalton, K. R. Anderson, K.-F. Lee, J. Rivier, K. R. Chien, W. W. Vale, and K. L. Peterson The cardiovascular physiologic actions of urocortin II: Acute effects in murine heart failure PNAS, March 9, 2004; 101(10): 3697 - 3702. [Abstract] [Full Text] [PDF]

				P. Steendijk, S. A. F. Tulner, J. J. Schreuder, J. J. Bax, L. van Erven, E. E. van der Wall, R. A. E. Dion, M. J. Schalij, and J. Baan Quantification of left ventricular mechanical dyssynchrony by conductance catheter in heart failure patients Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H723 - H730. [Abstract] [Full Text] [PDF]

				H. Senzaki, C.-H. Chen, S. Masutani, M. Taketazu, J. Kobayashi, T. Kobayashi, N. Sasaki, H. Asano, S. Kyo, and Y. Yokote Assessment of cardiovascular dynamics by pressure-area relations in pediatric patients with congenital heart disease J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 535 - 547. [Abstract] [Full Text] [PDF]

				G. Esposito, L. F. Santana, K. Dilly, J. D. S. Cruz, L. Mao, W. J. Lederer, and H. A. Rockman Cellular and functional defects in a mouse model of heart failure Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H3101 - H3112. [Abstract] [Full Text] [PDF]

				C.-H. Chen, C.-T. Ting, S.-J. Lin, T.-L. Hsu, S.-J. Ho, P. Chou, M.-S. Chang, F. O'Connor, H. Spurgeon, E. Lakatta, et al. Which Arterial and Cardiac Parameters Best Predict Left Ventricular Mass? Circulation, August 4, 1998; 98(5): 422 - 428. [Abstract] [Full Text] [PDF]

				Y. Ochiai, S. Morita, Y. Tanoue, Y. Kawachi, R. Tominaga, and H. Yasui Effects of amrinone, a phosphodiesterase inhibitor, on right ventricular/arterial coupling immediately after cardiac operations J. Thorac. Cardiovasc. Surg., July 1, 1998; 116(1): 139 - 147. [Abstract] [Full Text]